Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corbin J Eule

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advances in Radiation Oncology|December 2, 2024
Time to Next Systemic Therapy After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Castrate-Resistant Prostate CancerCorbin J Eule, Nellowe Candelario, Sameer K Nath, et al.
Prostate Cancer and Prostatic Diseases|November 19, 2022
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterationsCorbin J Eule, Thomas W Flaig, Katy Wong, et al.
Frontiers in Oncology|June 13, 2025
Clinical features and mutational frequency of renal cell carcinoma from patients undergoing kidney transplant evaluationCorbin J Eule, Junxiao Hu, Kurtis D Davies, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancerEryn B Callihan, Elizabeth Molina Kuna, Corbin J Eule, et al.
Urologic Oncology|August 27, 2024
Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ DatabaseCorbin J Eule, Elizabeth Molina Kuna, Tyler P Robin, et al.
Urology|April 30, 2024
Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred RegimenCorbin J Eule, Adam Warren, Elizabeth Molina Kuna, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2024
Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology databaseCorbin J Eule, Adam Warren, Elizabeth Molina Kuna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2025
Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association studyMichael K Jones, Andrew Nicklawsky, Jonathan Shortt, et al.
Cancers|May 25, 2024
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional DatabaseCorbin J Eule, Junxiao Hu, Dale Hedges, et al.
Advances in Urology|December 30, 2024
Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology PracticesBrett M Wiesen, Thomas W Flaig, Boris Gershman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advances in Radiation Oncology|December 2, 2024
Time to Next Systemic Therapy After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Castrate-Resistant Prostate CancerCorbin J Eule, Nellowe Candelario, Sameer K Nath, et al.
Prostate Cancer and Prostatic Diseases|November 19, 2022
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterationsCorbin J Eule, Thomas W Flaig, Katy Wong, et al.
Frontiers in Oncology|June 13, 2025
Clinical features and mutational frequency of renal cell carcinoma from patients undergoing kidney transplant evaluationCorbin J Eule, Junxiao Hu, Kurtis D Davies, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancerEryn B Callihan, Elizabeth Molina Kuna, Corbin J Eule, et al.
Urologic Oncology|August 27, 2024
Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ DatabaseCorbin J Eule, Elizabeth Molina Kuna, Tyler P Robin, et al.
Urology|April 30, 2024
Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred RegimenCorbin J Eule, Adam Warren, Elizabeth Molina Kuna, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2024
Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology databaseCorbin J Eule, Adam Warren, Elizabeth Molina Kuna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2025
Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association studyMichael K Jones, Andrew Nicklawsky, Jonathan Shortt, et al.
Cancers|May 25, 2024
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional DatabaseCorbin J Eule, Junxiao Hu, Dale Hedges, et al.
Advances in Urology|December 30, 2024
Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology PracticesBrett M Wiesen, Thomas W Flaig, Boris Gershman, et al.
Pageof 2